India manufactures APIs for over 400 FDA-approved orphan drugs, but patients face high costs due to Indian pharma companies' reluctance to develop these drugs domestically.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/yp4mG8g
via IFTTT
-
Acquista ********, Ossicodone, Ketamina, Ozempic (WhatsApp: +31616337954) I nostri prodotti hanno una purezza del 98-99%. E-mail di cont...
-
Vaccine manufacturer Serum Institute of India (SSI) has filed a challenge to the Supreme Court against a 2016 amendment to the Income Tax Ac...
-
Hey everyone, I’m looking to develop a dieting app that uses your food inventory to recommend recipes based on your caloric and macro needs....
Search This Blog
Powered by Blogger.
Blog Archive
-
▼
2024
(626)
-
▼
June
(59)
- US fund Platinum acquires Inventia Health in India...
- India's healthcare in critical condition: 4 out of...
- HCG acquires Vizag based cancer hospital for enter...
- India to make drugs for diabetes, obesity under PL...
- Why self-medicating without consulting a dermatolo...
- Risk-based audits of drug units to begin from July 1
- WHO warns alarming levels of physical inactivity a...
- India pharma units fare better in US checks in 2023
- Norms soon on disposing of expired medicines
- Dr Reddy's to buy nicotine replacement brands from...
- Diabetes management made easier: Your guide to a h...
- World's first epilepsy device fitted in 13 year ol...
- US lawmakers questions FDAs drug inspection progra...
- Everstone to merge two healthcare companies, list ...
- High costs of orphan drugs: Patients pay the price...
- Biocon Biologics gets EMA nod to produce biosimila...
- Govt widens composition of drug, medical devices p...
- Taller, stronger, sharper: Desi pharma is on a roll
- Lupin, Eugia recall products from US market: USFDA
- Biocon gets 4 observations from USFDA for Andhra P...
- Sun Pharma, Cipla enter licensing agreement with T...
- Sun Pharma inks pact with Takeda to introduce gast...
- Look-alike, sounding similar drugs likely to face ...
- Biocon seeks partner to test generic Wegovy, Ozemp...
- Emcure Pharmaceuticals receives SEBI nod for its I...
- Delivery boxes unhealthy: Nutritionist calls out S...
- Ozempic frenzy lures rich Indians to brave the gra...
- Expert panel to soon weigh plan to use generics fo...
- Cipla makes additional investment in German mRNA b...
- Alembic Pharma gets USFDA nod for Dabigatran Etexi...
- Lupin enters CDMO business, names Abdelaziz Toumi ...
- Lupin appoints Abdelaziz Toumi as CEO of newly for...
- Jaypee Healthcare admitted for corporate insolvenc...
- Health Ministry issues interdepartmental referral ...
- Bharat Bio's Rotavirus vaccine Rotovac may be unsa...
- Sun Pharma-Moebius Medical anti-osteoarthritis inj...
- Govt allows global tenders to access 120 key, pate...
- City dwellers rely more on Ayush than rural folk, ...
- Suven Pharma to acquire controlling stake in Hyder...
- USFDA issues Form 483 with five observations to To...
- Dr Reddy's signs in-licensing pact with Ingenus Ph...
- Glenmark gets USFDA nod to market generic drug
- Kotak Alt funds Matrix founder's buyout of Viatris...
- Kotak Alternate Asset Managers invests Rs 1,445 cr...
- Viagra may improve brain functions, prevent dement...
- SII, the world’s largest vaccine maker, sees deman...
- CX Partners buys controlling stake in fertility ce...
- Mankind Pharma in race with PEs to buy BSV Group a...
- Pharma industry raises concerns over new Schedule ...
- Mankind Pharma scouts for M&A deals to boost local...
- CDSCO panel gives nod for continuation of phase-II...
- Indoco Remedies gets USFDA nod to market generic d...
- Human death from bird flu: What is bird flu? Signs...
- Torrent Pharma inks licensing pact with Takeda to ...
- Govt issues guidance paper to strengthen vaccine c...
- Organon appoints Vivek Soares as country lead for ...
- US-based Zeda plans to raise up to $200 million fo...
- GSK blood cancer drug nearly halves risk of death ...
- Sun Pharma expects high single-digit top line grow...
-
▼
June
(59)
Recent Posts
Unordered List
Theme Support
-
Text Widget
Design by FlexiThemes | Blogger Theme by Lasantha - PremiumBloggerTemplates.com | Best Gadgets | Distributed By Gooyaabi Templates
0 comments:
Post a Comment